a phase ii study of interferon alfa-2a was conducted in 64 patients with multiple myeloma ( 42 igg , 16 iga , 5 bence-jones type , and 1 igd ) in a multi-institutional cooperative trial .
C0021734
interferon alfa-2a
C0026764
multiple myeloma